TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Biomea Fusion Announces KOL Presentation and Interview on Menin and Icovamenib at WCIRDC 2025

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Dr. Ralph Defronzo
Biomea Fusion Announces KOL Presentation and Interview on Menin and Icovamenib at WCIRDC 2025

Dr. Ralph DeFronzo presented insights on icovamenib, a potential disease-modifying therapy for diabetes, highlighting its ability to restore beta cell mass and function through menin inhibition during the 23rd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease.

Insights
BMEA   positive

Company is presenting promising clinical research on a novel diabetes treatment approach with potential to address significant unmet medical needs in diabetes care